5FOB image
Deposition Date 2015-11-18
Release Date 2016-04-06
Last Version Date 2024-10-16
Entry Detail
PDB ID:
5FOB
Title:
Crystal Structure of Human Complement C3b in complex with Smallpox Inhibitor of Complement (SPICE)
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.22
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:COMPLEMENT C3 BETA CHAIN
Gene (Uniprot):C3
Chain IDs:A
Chain Length:645
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Molecule:COMPLEMENT C3B ALPHA' CHAIN
Gene (Uniprot):C3
Chain IDs:B
Chain Length:915
Number of Molecules:1
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Molecule:SMALLPOX INHIBITOR OF COMPLEMENT SPICE, D15L
Gene (Uniprot):D15L
Chain IDs:C
Chain Length:245
Number of Molecules:1
Biological Source:VARIOLA MAJOR VIRUS
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Primary Citation
Regulators of Complement Activity Mediate Inhibitory Mechanisms Through a Common C3B-Binding Mode.
Embo J. 35 1133 ? (2016)
PMID: 27013439 DOI: 10.15252/EMBJ.201593673

Abstact

Regulators of complement activation (RCA) inhibit complement-induced immune responses on healthy host tissues. We present crystal structures of human RCA (MCP, DAF, and CR1) and a smallpox virus homolog (SPICE) bound to complement component C3b. Our structural data reveal that up to four consecutive homologous CCP domains (i-iv), responsible for inhibition, bind in the same orientation and extended arrangement at a shared binding platform on C3b. Large sequence variations in CCP domains explain the diverse C3b-binding patterns, with limited or no contribution of some individual domains, while all regulators show extensive contacts with C3b for the domains at the third site. A variation of ~100° rotation around the longitudinal axis is observed for domains binding at the fourth site on C3b, without affecting the overall binding mode. The data suggest a common evolutionary origin for both inhibitory mechanisms, called decay acceleration and cofactor activity, with variable C3b binding through domains at sites ii, iii, and iv, and provide a framework for understanding RCA disease-related mutations and immune evasion.

Legend

Protein

Chemical

Disease

Primary Citation of related structures